Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 3/2011

Open Access 01-12-2011 | Review

Protective efficacy of malaria case management for preventing malaria mortality in children: a systematic review for the Lives Saved Tool

Authors: Julie Thwing, Thomas P Eisele, Richard W Steketee

Published in: BMC Public Health | Special Issue 3/2011

Login to get access

Abstract

Background

The Lives Saved Tool (LiST) model was developed to estimate the impact of the scale-up of child survival interventions on child mortality. New advances in antimalarials have improved their efficacy of treating uncomplicated and severe malaria. Artemisinin-based combination therapies (ACTs) for uncomplicated Plasmodium falciparum malaria and parenteral or rectal artemisinin or quinine for severe malaria syndromes have been shown to be very effective for the treatment of malaria in children. These interventions are now being considered for inclusion in the LiST model. However, for obvious ethical reasons, their protective efficacy (PE) compared to placebo is unknown and their impact on reducing malaria-attributable mortality has not been quantified.

Methods

We performed systematic literature reviews of published studies in P. falciparum endemic settings to determine the protective efficacy (PE) of ACT treatment against malaria deaths among children with uncomplicated malaria, as well as the PE of effective case management including parenteral quinine against malaria deaths among all hospitalized children. As no randomized placebo-controlled trials of malaria treatment have been conducted, we used multiple data sources to ascertain estimates of PE, including a previously performed Delphi estimate for treatment of uncomplicated malaria.

Results

Based on multiple data sources, we estimate the PE of ACT treatment of uncomplicated P. falciparum malaria on reducing malaria mortality in children 1–23 months to be 99% (range: 94-100%), and in children 24-59 months to be 97% (range: 86-99%). We estimate the PE of treatment of severe P. falciparum malaria with effective case management including intravenous quinine on reducing malaria mortality in children 1-59 months to be 82% (range: 63-94%) compared to no treatment.

Conclusions

This systematic review quantifies the PE of ACT used for treating uncomplicated malaria and effective case management including parenteral quinine for treating severe P. falciparum malaria for preventing malaria mortality in children <5. These data will be used in the Lives Saved Tool (LiST) model for estimating the impact of scaling-up these interventions against malaria. However, in order to estimate the reduction in child mortality due to scale-up of these interventions, it is imperative to develop standardized indicators to measure population coverage of these interventions.
Appendix
Available only for authorised users
Literature
1.
Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, Noor AM, Kabaria CW, Manh BH, Elyazar IR, Brooker S, et al: A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med. 2009, 6 (3): e1000048-10.1371/journal.pmed.1000048.PubMedCentralCrossRefPubMed
2.
WHO: World Malaria Report 2008. Edited by: WHO. 2008, Geneva: WHO
3.
Sinclair D, Zani B, Donegan S, Olliaro P, Garner P: Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane database of systematic reviews (Online). 2009, CD007483-3
4.
Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N: Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004, 363 (9402): 9-17. 10.1016/S0140-6736(03)15162-8.CrossRefPubMed
5.
WHO: World Malaria Report 2009. Edited by: WHO. 2009, Geneva: WHO
6.
McIntosh HM, Olliaro P: Artemisinin derivatives for treating severe malaria. Cochrane database of systematic reviews (Online). 2000, CD000527-2
7.
Day N, Dondorp AM: The management of patients with severe malaria. The American journal of tropical medicine and hygiene. 2007, 77 (6 Suppl): 29-35.PubMed
8.
Karunajeewa HA, Manning L, Mueller I, Ilett KF, Davis TM: Rectal administration of artemisinin derivatives for the treatment of malaria. JAMA. 2007, 297 (21): 2381-2390. 10.1001/jama.297.21.2381.CrossRefPubMed
9.
Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, et al: Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010, 376 (9753): 1647-1657. 10.1016/S0140-6736(10)61924-1.PubMedCentralCrossRefPubMed
10.
Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS: How many child deaths can we prevent this year?. Lancet. 2003, 362 (9377): 65-71. 10.1016/S0140-6736(03)13811-1.CrossRefPubMed
11.
Walker N, Fischer-Walker C, Bryce J, Bahl R, Cousens S: Standards for CHERG reviews of intervention effects on child survival. Int J Epidemiol. 2010, 39 (Suppl 1): i21-31. 10.1093/ije/dyq036.PubMedCentralCrossRefPubMed
12.
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, et al: Grading quality of evidence and strength of recommendations. Bmj. 2004, 328 (7454): 1490-10.1136/bmj.328.7454.1490.CrossRefPubMed
13.
Zucker JR: Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg Infect Dis. 1996, 2 (1): 37-43. 10.3201/eid0201.960104.PubMedCentralCrossRefPubMed
14.
Sudre P, Breman JG, Koplan JP: Delphi survey of malaria mortality and drug resistance in Africa. Lancet. 1990, 335 (8691): 722-10.1016/0140-6736(90)90833-Q.CrossRefPubMed
15.
Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ: Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malaria journal. 2008, 7: 127-10.1186/1475-2875-7-127.PubMedCentralCrossRefPubMed
16.
Ashley EA, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung R, Wilairatana P, Brockman A, Looareesuwan S, et al: Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. The Journal of infectious diseases. 2004, 190 (10): 1773-1782. 10.1086/425015.CrossRefPubMed
17.
Ashley EA, McGready R, Hutagalung R, Phaiphun L, Slight T, Proux S, Thwai KL, Barends M, Looareesuwan S, White NJ, et al: A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis. 2005, 41 (4): 425-432. 10.1086/432011.CrossRefPubMed
18.
Ashley EA, Lwin KM, McGready R, Simon WH, Phaiphun L, Proux S, Wangseang N, Taylor W, Stepniewska K, Nawamaneerat W, et al: An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Trop Med Int Health. 2006, 11 (11): 1653-1660. 10.1111/j.1365-3156.2006.01724.x.CrossRefPubMed
19.
Bonnet M, Roper C, Felix M, Coulibaly L, Kankolongo GM, Guthmann JP: Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zerekore. Malaria journal. 2007, 6: 54-10.1186/1475-2875-6-54.PubMedCentralCrossRefPubMed
20.
Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, et al: Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. The Journal of infectious diseases. 2006, 193 (8): 1151-1159. 10.1086/503051.CrossRefPubMed
21.
Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, Bakyaita N, Rwakimari JB, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, et al: Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials. 2006, 1 (1): e7-10.1371/journal.pctr.0010007.PubMedCentralCrossRefPubMed
22.
Djimde AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, Dama S, Ouologuem D, Dicko A, Doumbo OK: Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. The American journal of tropical medicine and hygiene. 2008, 78 (3): 455-461.PubMed
23.
Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ: Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007, 297 (20): 2210-2219. 10.1001/jama.297.20.2210.CrossRefPubMed
24.
Falade CO, Ogundele AO, Yusuf BO, Ademowo OG, Ladipo SM: High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. Trop Med Int Health. 2008, 13 (5): 635-643. 10.1111/j.1365-3156.2008.02043.x.CrossRefPubMed
25.
Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D'Alessandro U: A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Trans R Soc Trop Med Hyg. 2007, 101 (4): 344-350. 10.1016/j.trstmh.2006.06.010.CrossRefPubMed
26.
Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O: Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Malaria journal. 2007, 6: 80-10.1186/1475-2875-6-80.PubMedCentralCrossRefPubMed
27.
Grande T, Bernasconi A, Erhart A, Gamboa D, Casapia M, Delgado C, Torres K, Fanello C, Llanos-Cuentas A, D'Alessandro U: A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS ONE. 2007, 2 (10): e1101-10.1371/journal.pone.0001101.PubMedCentralCrossRefPubMed
28.
Guthmann JP, Ampuero J, Fortes F, van Overmeir C, Gaboulaud V, Tobback S, Dunand J, Saraiva N, Gillet P, Franco J, et al: Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg. 2005, 99 (7): 485-492. 10.1016/j.trstmh.2004.11.010.CrossRefPubMed
29.
Guthmann JP, Cohuet S, Rigutto C, Fortes F, Saraiva N, Kiguli J, Kyomuhendo J, Francis M, Noel F, Mulemba M, et al: High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. The American journal of tropical medicine and hygiene. 2006, 75 (1): 143-145.PubMed
30.
Hamour S, Melaku Y, Keus K, Wambugu J, Atkin S, Montgomery J, Ford N, Hook C, Checchi F: Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. Trans R Soc Trop Med Hyg. 2005, 99 (7): 548-554. 10.1016/j.trstmh.2004.10.003.CrossRefPubMed
31.
Hasugian AR, Purba HL, Kenangalem E, Wuwung RM, Ebsworth EP, Maristela R, Penttinen PM, Laihad F, Anstey NM, Tjitra E, et al: Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis. 2007, 44 (8): 1067-1074. 10.1086/512677.PubMedCentralCrossRefPubMed
32.
Hutagalung R, Paiphun L, Ashley EA, McGready R, Brockman A, Thwai KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH: A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Malaria journal. 2005, 4: 46-10.1186/1475-2875-4-46.PubMedCentralCrossRefPubMed
33.
Janssens B, van Herp M, Goubert L, Chan S, Uong S, Nong S, Socheat D, Brockman A, Ashley EA, Van Damme W: A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health. 2007, 12 (2): 251-259. 10.1111/j.1365-3156.2006.01786.x.CrossRefPubMed
34.
Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, Talisuna AO, Greenhouse B, Nosten F, Rosenthal PJ, et al: Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials. 2007, 2 (5): e20-10.1371/journal.pctr.0020020.PubMedCentralCrossRefPubMed
35.
Karema C, Fanello CI, van Overmeir C, van Geertruyden JP, van Doren W, Ngamije D, D'Alessandro U: Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans R Soc Trop Med Hyg. 2006, 100 (12): 1105-1111. 10.1016/j.trstmh.2006.01.001.CrossRefPubMed
36.
Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, et al: A trial of combination antimalarial therapies in children from Papua New Guinea. The New England journal of medicine. 2008, 359 (24): 2545-2557. 10.1056/NEJMoa0804915.CrossRefPubMed
37.
Kayentao K, Maiga H, Newman RD, McMorrow ML, Hoppe A, Yattara O, Traore H, Kone Y, Guirou EA, Saye R, et al: Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali. Malaria journal. 2009, 8: 5-10.1186/1475-2875-8-5.PubMedCentralCrossRefPubMed
38.
Kobbe R, Klein P, Adjei S, Amemasor S, Thompson WN, Heidemann H, Nielsen MV, Vohwinkel J, Hogan B, Kreuels B, et al: A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children. Malaria journal. 2008, 7: 261-10.1186/1475-2875-7-261.PubMedCentralCrossRefPubMed
39.
Koram KA, Abuaku B, Duah N, Quashie N: Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta tropica. 2005, 95 (3): 194-203. 10.1016/j.actatropica.2005.06.018.CrossRefPubMed
40.
Lefevre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R: A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. The American journal of tropical medicine and hygiene. 2001, 64 (5-6): 247-256.PubMed
41.
Martensson A, Stromberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Bjorkman A: Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis. 2005, 41 (8): 1079-1086. 10.1086/444460.CrossRefPubMed
42.
Mayxay M, Khanthavong M, Lindegardh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, et al: Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. Clin Infect Dis. 2004, 39 (8): 1139-1147. 10.1086/424512.CrossRefPubMed
43.
Menard D, Andrianina NN, Ramiandrasoa Z, Randriamanantena A, Rasoarilalao N, Jahevitra M, Ratsimbasoa A, Tuseo L, Raveloson A: Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar. Malaria journal. 2007, 6: 65-10.1186/1475-2875-6-65.PubMedCentralCrossRefPubMed
44.
Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HD, Kager PA: A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Malaria journal. 2008, 7: 237-10.1186/1475-2875-7-237.PubMedCentralCrossRefPubMed
45.
Mukhtar EA, Gadalla NB, El-Zaki SE, Mukhtar I, Mansour FA, Babiker A, El-Sayed BB: A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan. Malaria journal. 2007, 6: 92-10.1186/1475-2875-6-92.PubMedCentralCrossRefPubMed
46.
Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ: Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet. 2005, 365 (9469): 1474-1480. 10.1016/S0140-6736(05)66417-3.CrossRefPubMed
47.
Owusu-Agyei S, Asante KP, Owusu R, Adjuik M, Amenga-Etego S, Dosoo DK, Gyapong J, Greenwood B, Chandramohan D: An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. PLoS ONE. 2008, 3 (6): e2530-10.1371/journal.pone.0002530.PubMedCentralCrossRefPubMed
48.
Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN: Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet. 2007, 369 (9563): 757-765. 10.1016/S0140-6736(07)60160-3.PubMedCentralCrossRefPubMed
49.
Sagara I, Diallo A, Kone M, Coulibaly M, Diawara SI, Guindo O, Maiga H, Niambele MB, Sissoko M, Dicko A, et al: A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. The American journal of tropical medicine and hygiene. 2008, 79 (5): 655-661.PubMed
50.
Smithuis F, Kyaw MK, Phe O, Aye KZ, Htet L, Barends M, Lindegardh N, Singtoroj T, Ashley E, Lwin S, et al: Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet. 2006, 367 (9528): 2075-2085. 10.1016/S0140-6736(06)68931-9.CrossRefPubMed
51.
Staedke SG, Mpimbaza A, Kamya MR, Nzarubara BK, Dorsey G, Rosenthal PJ: Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. Lancet. 2004, 364 (9449): 1950-1957. 10.1016/S0140-6736(04)17478-3.CrossRefPubMed
52.
Stohrer JM, Dittrich S, Thongpaseuth V, Vanisaveth V, Phetsouvanh R, Phompida S, Monti F, Christophel EM, Lindegardh N, Annerberg A, et al: Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. Trop Med Int Health. 2004, 9 (11): 1175-1183. 10.1111/j.1365-3156.2004.01320.x.CrossRefPubMed
53.
Swarthout TD, van den Broek IV, Kayembe G, Montgomery J, Pota H, Roper C: Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. Trop Med Int Health. 2006, 11 (10): 1503-1511. 10.1111/j.1365-3156.2006.01710.x.CrossRefPubMed
54.
Tangpukdee N, Krudsood S, Thanachartwet W, Chalermrut K, Pengruksa C, Srivilairit S, Silachamroon U, Wilairatana P, Phongtananant S, Kano S, et al: An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. The Southeast Asian journal of tropical medicine and public health. 2005, 36 (5): 1085-1091.PubMed
55.
Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, et al: Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet. 2004, 363 (9402): 18-22. 10.1016/S0140-6736(03)15163-X.CrossRefPubMed
56.
van den Broek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M, Rahman MR, Bangali AM, Das S, Barends M, et al: Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. Trans R Soc Trop Med Hyg. 2005, 99 (10): 727-735. 10.1016/j.trstmh.2005.02.007.CrossRefPubMed
57.
van den Broek I, Kitz C, Al Attas S, Libama F, Balasegaram M, Guthmann JP: Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. Malaria journal. 2006, 5: 113-10.1186/1475-2875-5-113.PubMedCentralCrossRefPubMed
58.
van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F: Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg. 2000, 94 (5): 545-548. 10.1016/S0035-9203(00)90082-8.CrossRefPubMed
59.
Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, et al: Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med. 2005, 2 (7): e190-10.1371/journal.pmed.0020190.PubMedCentralCrossRefPubMed
60.
Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H: Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS ONE. 2008, 3 (6): e2390-10.1371/journal.pone.0002390.PubMedCentralCrossRefPubMed
61.
Zongo I, Dorsey G, Rouamba N, Tinto H, Dokomajilar C, Guiguemde RT, Rosenthal PJ, Ouedraogo JB: Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet. 2007, 369 (9560): 491-498. 10.1016/S0140-6736(07)60236-0.CrossRefPubMed
62.
Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Sere Y, Rosenthal PJ, Ouedraogo JB: Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis. 2007, 45 (11): 1453-1461. 10.1086/522985.CrossRefPubMed
63.
Mayxay M, Thongpraseuth V, Khanthavong M, Lindegardh N, Barends M, Keola S, Pongvongsa T, Phompida S, Phetsouvanh R, Stepniewska K, et al: An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos). Trop Med Int Health. 2006, 11 (8): 1157-1165. 10.1111/j.1365-3156.2006.01671.x.CrossRefPubMed
64.
Assimadi JK, Gbadoe AD, Atakouma DY, Agbenowossi K, Lawson-Evi K, Gayibor A, Kassankogno Y: Severe malaria in children in Togo. Arch Pediatr. 1998, 5 (12): 1310-1315. 10.1016/S0929-693X(99)80048-7.CrossRefPubMed
65.
Bassat Q, Guinovart C, Sigauque B, Aide P, Sacarlal J, Nhampossa T, Bardaji A, Nhacolo A, Macete E, Mandomando I, et al: Malaria in rural Mozambique. Part II: children admitted to hospital. Malaria journal. 2008, 7: 37-10.1186/1475-2875-7-37.PubMedCentralCrossRefPubMed
66.
Campbell JD, Sow SO, Levine MM, Kotloff KL: The causes of hospital admission and death among children in Bamako, Mali. Journal of tropical pediatrics. 2004, 50 (3): 158-163. 10.1093/tropej/50.3.158.CrossRefPubMed
67.
Greenberg AE, Ntumbanzondo M, Ntula N, Mawa L, Howell J, Davachi F: Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull World Health Organ. 1989, 67 (2): 189-196.PubMedCentralPubMed
68.
Issifou S, Kendjo E, Missinou MA, Matsiegui PB, Dzeing-Ella A, Dissanami FA, Kombila M, Krishna S, Kremsner PG: Differences in presentation of severe malaria in urban and rural Gabon. The American journal of tropical medicine and hygiene. 2007, 77 (6): 1015-1019.PubMed
69.
Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, et al: Indicators of life-threatening malaria in African children. The New England journal of medicine. 1995, 332 (21): 1399-1404. 10.1056/NEJM199505253322102.CrossRefPubMed
70.
Mockenhaupt FP, Ehrhardt S, Burkhardt J, Bosomtwe SY, Laryea S, Anemana SD, Otchwemah RN, Cramer JP, Dietz E, Gellert S, et al: Manifestation and outcome of severe malaria in children in northern Ghana. The American journal of tropical medicine and hygiene. 2004, 71 (2): 167-172.PubMed
71.
Schellenberg D, Menendez C, Kahigwa E, Font F, Galindo C, Acosta C, Schellenberg JA, Aponte JJ, Kimario J, Urassa H, et al: African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. The American journal of tropical medicine and hygiene. 1999, 61 (3): 431-438.PubMed
72.
Waller D, Krishna S, Crawley J, Miller K, Nosten F, Chapman D, ter Kuile FO, Craddock C, Berry C, Holloway PA, et al: Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis. 1995, 21 (3): 577-587. 10.1093/clinids/21.3.577.CrossRefPubMed
73.
Winkler AS, Salmhofer G, Helbok R, Kalokola F, Matuja W, Schmutzhard E: In-hospital risk estimation in children with malaria--early predictors of morbidity and mortality. Journal of tropical pediatrics. 2008, 54 (3): 184-191. 10.1093/tropej/fmm108.CrossRefPubMed
74.
Zucker JR, Campbell CC: Malaria. Principles of prevention and treatment. Infect Dis Clin North Am. 1993, 7 (3): 547-567.PubMed
75.
Zucker JR, Lackritz EM, Ruebush TK, Hightower AW, Adungosi JE, Were JB, Campbell CC: Anaemia, blood transfusion practices, HIV and mortality among women of reproductive age in western Kenya. Trans R Soc Trop Med Hyg. 1994, 88 (2): 173-176. 10.1016/0035-9203(94)90283-6.CrossRefPubMed
76.
Biai S, Rodrigues A, Gomes M, Ribeiro I, Sodemann M, Alves F, Aaby P: Reduced in-hospital mortality after improved management of children under 5 years admitted to hospital with malaria: randomised trial. BMJ. 2007, 335 (7625): 862-10.1136/bmj.39345.467813.80.PubMedCentralCrossRefPubMed
77.
Idro R, Aloyo J: Manifestations, quality of emergency care and outcome of severe malaria in Mulago Hospital, Uganda. Afr Health Sci. 2004, 4 (1): 50-57.PubMedCentralPubMed
78.
Oduro AR, Koram KA, Rogers W, Atuguba F, Ansah P, Anyorigiya T, Ansah A, Anto F, Mensah N, Hodgson A, et al: Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. Malaria journal. 2007, 6: 96-10.1186/1475-2875-6-96.PubMedCentralCrossRefPubMed
79.
Ranque S, Poudiougou B, Traore A, Keita M, Oumar AA, Safeukui I, Marquet S, Cabantous S, Diakite M, Mintha D, et al: Life-threatening malaria in African children: a prospective study in a mesoendemic urban setting. Pediatr Infect Dis J. 2008, 27 (2): 130-135.PubMed
80.
Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, Olomi R, Cox J, Nkya WM, Lemnge M, Greenwood BM, et al: Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA. 2005, 293 (12): 1461-1470. 10.1001/jama.293.12.1461.CrossRefPubMed
81.
Trape JF: The public health impact of chloroquine resistance in Africa. The American journal of tropical medicine and hygiene. 2001, 64 (1-2 Suppl): 12-17.PubMed
82.
Zucker JR, Ruebush TK, Obonyo C, Otieno J, Campbell CC: The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. The American journal of tropical medicine and hygiene. 2003, 68 (4): 386-390.PubMed
83.
Diallo D, Graz B, Falquet J, Traore AK, Giani S, Mounkoro PP, Berthe A, Sacko M, Diakite C: Malaria treatment in remote areas of Mali: use of modern and traditional medicines, patient outcome. Trans R Soc Trop Med Hyg. 2006, 100 (6): 515-520. 10.1016/j.trstmh.2005.08.003.CrossRefPubMed
84.
RBM: Guidelines for Core Population-based Indicators. 2008, Maryland: Roll Back Malaria, MEASURE Evaluation, World Health Organization, UNICEF
Metadata
Title
Protective efficacy of malaria case management for preventing malaria mortality in children: a systematic review for the Lives Saved Tool
Authors
Julie Thwing
Thomas P Eisele
Richard W Steketee
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue Special Issue 3/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-S3-S14

Other articles of this Special Issue 3/2011

BMC Public Health 3/2011 Go to the issue

Methodology

Comparing estimates of child mortality reduction modelled in LiST with pregnancy history survey data for a community-based NGO project in Mozambique

Review

Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries

Research

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children

Research

An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children

Review

Care during labor and birth for the prevention of intrapartum-related neonatal deaths: a systematic review and Delphi estimation of mortality effect

Review

Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect